• All
  • Acquisitions
  • Events
  • Executive Search
  • Finance
  • News
  • Press Releases
  • Uncategorized
  • Views

BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (NASDAQ: BBLG) (“Bone Biologics” or the “Company”), a developer of orthobiologic products for spine fusion markets, today announced the pricing of an underwritten public offering of...